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Vitamin D and Mental health: The role of the “sunshine vitamin” 
 
Abstract  
The importance of vitamin D in physical disorders has been well documented. 
Deficiency in this vitamin is associated with a wide range of physical and mental 
disorders that include, heart problems, hypertension, stroke, diabetes, various 
cancers, and asthma. In mental health vitamin D deficiency is associated with 
schizophrenia, depression, anxiety, Alzheimer’s disease among others. Risk factors 
for vitamin D deficiency include darker skin, lack of adequate sun exposure, 
autoimmune diseases, influenza, old age and the use of certain medicines like 
anticonvulsants. Vitamin D is likely to play an important role in the management and 
prevention of various mental health problems. In particular, adequate vitamin D 
during the perinatal stage is likely to impact positively on the long term mental health 
of a person.  
 
Introduction  
Until recently, the importance of Vitamin D, nicknamed “the sunshine vitamin,” has 
not been fully appreciated with its relative importance only focusing on adult bone 
health (Holick 2005). However, current estimates suggest that over a billion people 
have either vitamin D insufficiency or deficiency (Holick 2007). Scientific evidence is 
mounting implicating its importance in a vast array of physical and mental health 
problems. In physical health, vitamin D deficiency(VDD) is associated with type 1 
diabetes (Mathieu et al. 2005), cardiovascular diseases (Baz-Hecht and Goldfine 
2010), multiple sclerosis (VanAmerongen et al. 2004), sleep disturbance, various 
cancers including colon, breast, prostate and lung (Pearce and Cheetham 2010). It is 
also associated with asthma, muscular degeneration, auto immune disturbance, 
hyperparathyroidism, osteoporosis, cell growth modulation, neuromuscular and 
immune function. Conversely, adequate levels of vitamin D are associated with a 
reduction of inflammation (Tariq et al. 2011), good bone formation, increasing the 
activities (upregulates) of some gene enzymes like osteocalcin, osteopontin, 
calbindin 24-hydroxylase among others. In addition, the hormonally active form of 
vitamin D called calcitriol, reduces the activities of inflammatory markers like 
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interleukin 1(IL-1) and IL-2. Calcitriol also stimulates cell differentiation, influences 
muscular function, and stimulates insulin secretion (Tariq et al. 2011). Vitamin D also 
plays a role in mortality and this is clearly underscored by a recent meta- analysis of 
14 eligible studies with 62548 participants showing that, VDD is associated with 
higher incidence of mortality (Zittermann et al. 2012). VDD also causes muscle 
weakness in children and the elderly with affected children having difficulty in 
standing and walking (Holick 2006) whereas the elderly have increasing sway and 
frequent falls (Bischoff-Ferrari et al. 2009). Clearly, the importance of vitamin D in 
physical health is self evident and this is true for mental health.  
 
In mental health, VDD is associated with a number of neurodevelopmental and 
endocrine disorders (Humble, 2010). Ailments include autism, depression, anxiety, 
schizophrenia, Alzheimer’s disease, premenstrual problems, thyroid regulation and 
sleep disorders among others. Because of the public health importance of Vitamin D, 
we carried out a selective review of evidence supporting the role of Vitamin D in 
some mental health disorders.  
In particular, the article reviews evidence supporting the role of VDD in serious 
mental illness as schizophrenia and depression. The article starts by reviewing the 
epidemiology of VDD before discussing the mechanism underlying Vitamin D 
manufacture in the skin and its role in neurodevelopment, schizophrenia and 
depression. Lastly, the implications for nursing and health in general are discussed.  
 
What is Vitamin D? 
Vitamin D is a steroid hormone (neurosteroid), meaning it comes from cholesterol 
precursors and its traditional role is enhancing the absorption and metabolism of 
calcium and phosphorous in the body. It affects the key biological functions of over 
2000 genes in the body responsible for hormone balance, cell growth and immune 
function. There are at least five known different forms of vitamin D but only Vitamin 
D2 (ergocalciferol) and Vitamin D3 (cholecalciferol) are clinically relevant. As a steroid 
hormone, it is formed from a substance in the skin called 7 dehydrocholesterol 
(7DHC) after skin is exposure to ultra violet beta (UVB) rays.  
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Intuitively, it is appealing that people living in sunny climates have sufficient Vitamin 
D levels but evidence suggest otherwise. Studies carried out in sunny climates like 
Hawaii, Turkey, India, Iran and Saudi Arabia show that there is a high prevalence of 
VDD in people living in these countries. The deficiency is almost similar to those 
living in high latitudes countries (Binkley et al. 2007; Lips 2007; Elsammak et al. 
2011).  There is growing tendency for indoor activities by people living in these 
countries and this partly explains these findings (Fields et al. 2011). Moreover, since 
the 1980’s the public has been warned against sunlight exposure to reduce the risk 
of developing skin cancer and this has played a contributory role in high VDD(Ness 
et al. 1999). In this regard, mental health patients in inpatient settings are at risk of 
VDD, therefore replenishing this important vitamin is necessary.  
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Risk factors for vitamin D deficiency 
In high latitudes of the Northern hemisphere countries, seasons strongly affect levels 
of vitamin D in the body. Several studies have found that in these countries, levels of 
vitamin D decrease during the winter months and increase during summer months 
(Rapuri et al. 2002). Wearing a sunscreen with a sun protection factor of 30 reduces 
vitamin D synthesis in the skin by more than 95%.(Matsuoka et al. 1987). Patients on 
a wide variety of medications, including anticonvulsants and medications to treat 
AIDS/HIV, are at risk because these drugs enhance the breakdown of vitamin D in 
the body (Zhou et al. 2006). In addition to the factors discussed, age is also a risk 
factor for VDD.  
Several studies have found an association between old age and VDD and this is due 
to atrophic changes of their skin which decreases their capacity to produce adequate 
amounts of vitamin D (Hirani and Primatesta 2005). Moreover, the capacity for 
humans to absorb dietary vitamin D through the gut diminish with age(Huotari and 
Herzig 2008). A study that examined the levels of vitamin D in older people (average 
age 69years) in Guatemala found that despite living in optimal climate for vitamin D, 
older Guatemalans had suboptimal levels of vitamin D(Sud et al. 2010). This finding 
is in line with a UK study found worryingly low levels of vitamin D in old people of 
65years or over (Hirani and Primatesta 2005). A further recent study found 
decreased Vitamin D level in older people in nursing homes (Verhoeven et al. 2012). 
By extrapolation, elderly people with mental health problems are equally at risk of 
VDD.  VDD is also common in people with darker skin.  
Consistent evidence exist clearly linking VDD and skin colour(Rockell et al. 2005; 
Rockell et al. 2008). Some studies in the USA have found that African-Americans are 
eight times more likely to be vitamin D deficient compared to age-matched 
Caucasians (Harris 2006; Bodnar et al. 2007) and this is supported by a more recent 
study a multiethnic sample of 503  adults(European, Maori, Pacific and Asian) in 
New Zealand. The study found that amongst these ethnic groups, Asians had the 
lowest mean Vitamin D levels and Europeans with lighter coloured skin had the 
highest (Nessvi et al. 2011). The main reason why darker skinned people are prone 
to VDD is darker skin (highly melanised) is less efficient at manufacturing vitamin D 
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than lighter skin. In addition to skin colour, obesity is also known to be a risk factor 
for VDD.  
There is an association between inadequate Vitamin D levels and obesity 
(Alemzadeh et al. 2008; Sanchez-Hernandez et al. 2005; Renzaho et al. 2011; Brock 
et al. 2010). A relatively recent systematic review of 14 studies found an association 
between VDD and obesity related disorders (Renzaho et al. 2011) and another study 
found a relationship between VDD and BMI index of above thirty (Brock et al. 2010). 
It is also known that obesity is a common problem in people with mental health 
ailments, therefore, VDD is likely to be prevalent in this population(Phelan et al. 
2001). More importantly, emerging evidence suggest a link between VDD and the 
aetiology of various mental health problems such as schizophrenia, depression, 
Alzheimer’s disease and anxiety. Specifically, there is a strong link between vitamin 
D and neurodevelopmental ailments. This is particularly provocative as we now 
consider a number of psychiatric illnesses neurodevelopmental in origin. For this 
reason, it is important to review evidence that support the link between VDD and 
neurodevelopment.  
Vitamin D and neurodevelopment  
The discovery of vitamin D metabolites in the cerebrospinal fluid offered the first 
direct clue of its functional role in the nervous system(Balabanova et al. 1984). 
Evidence from animal models suggests that in utero VDD leads to dysregulation of 
cell differentiation in the developing neonate rat brain. Maternal VDD effect on 
neonate brain development persist into adulthood even if sufficient vitamin D levels 
are restored after birth (Feron et al. 2005). Further evidence supporting VDD in brain 
function is the discovery of Vitamin D receptors in the brain of both rodents (Stumpf 
and O'Brien 1987)and human brain(Eyles et al. 2005).  
Vitamin D receptors (VDR) start to function as early as the 12th day of gestation and 
this coincides with the formation of dopamine neurons, a neurotransmitter implicated 
in psychiatric disorders such as schizophrenia and depression. VDR are involved in 
the differentiation of many brain areas throughout gestation (Cui et al. 2007). 
Furthermore, there is evidence suggesting VDR is involved in natural cell elimination 
(Ko et al., 2004). In addition, Vitamin D modulates nerve growth factors (NGF) 
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essential for the growth and survival of many neurons in the brain. Specifically, the 
cholinergic basal forebrain neurons are affected (Brown et al. 2003). This finding is in 
line with an earlier animal study that found that injecting vitamin D in ventricles of the 
brain induces nerve growth factor expression in the hippocampus of adult 
rats(Saporito et al. 1993). These findings have implications for pregnant women in 
human where an estimated 40% to 80% of pregnant women are vitamin D deficient. 
This VDD which has ramifications for subsequent brain function is more pronounced 
in dark skinned ethnic populations living at high latitudes countries. In combination 
with other factors, VDD during peri-natal life may establish a poor foundation that 
may produce long-term threats to human health that include risk for developing 
schizophrenia.  
Schizophrenia and vitamin D 
We now accept that schizophrenia is a heterogeneous disorder in which genetic and 
environmental factors interact to contribute to the person’s risk for developing the 
disorder (Eyles et al. 2009). To date, evidence linking VDD and schizophrenia is the 
tendency for people with schizophrenia to be born in the winter months or in higher 
latitudes countries (Torrey et al. 1997; Davies et al. 2003). In a review of 250 studies 
covering 29 Northern and five Southern Hemisphere countries, Torrey et al (1997) 
found an excess of people with schizophrenia and depression to be born in 
winter/spring months. This excess was not seen in other mental health disorders. 
The investigators concluded that, statistical artefact and parental procreational habits 
are insufficient explanations for this excess, which was as high 8%. In darker 
skinned individuals living in high latitudes countries, VDD assumes a greater 
importance as there is a high and disproportionate number of people with 
schizophrenia in this population (Fearon et al. 2006).  
 
More specifically, the relative risk of developing schizophrenia is higher in second 
than first generation darker skinned migrants who move to high latitude 
climates(Cantor-Graae and Selten 2005; Dealberto 2010). Because their 
vulnerability for VDD, darker skinned individuals increase the likelihood of VDD in 
their offsprings. This hypothesis is supported by several studies including one study 
that examined maternal VDD as a risk factor for schizophrenia in offsprings using 
banked maternal sera(McGrath et al. 2003). The study found that the offspring of 
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darker skinned mothers were more likely to develop schizophrenia if the mother had 
significantly low vitamin D levels especially in the third trimester of pregnancy. By 
contrast, the chances of the offspring developing schizophrenia were significantly 
reduced if their mothers had normal vitamin D level during the same period of 
pregnancy (McGrath et al 2003).  
A study that provided direct evidence of the relationship between VDD and the risk of 
developing  schizophrenia is the Northern Finnish cohort study(Ko et al. 2004). The 
study found a reduced risk of developing schizophrenia in male offspring who 
received adequate vitamin D supplementation than males who did not in their first 
year of life. This finding is supported by a relatively recent study that examined the 
link between neonatal vitamin D status and risk of schizophrenia (McGrath et al. 
2010). The study assessed the concentration of Vitamin D from neonatal dried blood 
samples of individuals with schizophrenia and controls. Low or very high levels of 
vitamin D were associated with a risk for developing schizophrenia, suggesting a non 
linear relationship. Overall, VDD appear to a have a link in mental health disorders 
like schizophrenia and depression.  
Depression 
Evidence supporting the role of vitamin D in depression comes from three main 
sources namely, animal models, epidemiological and, randomised controlled studies. 
In animal models, mice lacking vitamin D receptor functioning show behavioural 
impairment that include, memory, perseverative responses and hypolocomotion and 
these behaviours are seen in hums with depression. Rodents with VDD show 
dysfunctional noradrenalin gene expression. In humans, noradrenaline is implicated 
in depression therefore lending indirect evidence for the role of vitamin D in 
depression. Animal studies also suggest a role for vitamin D in neuroprotection 
against the effects of dopamine toxins such as methamphetamine. Like 
noradrenaline, dopamine is implicated in depression (Cass et al. 2006). Cass et al 
(2006) exposed rats to the dopamine toxin, methamphetamine and the rats 
experienced a significant decrease in serotonin and dopamine concentration in the 
brain but rats treated with vitamin D did not demonstrate these effects. Cass et 
al(2006) study is compatible with an earlier finding that showed an increase in 
dopamine in the cortical region of the brain in rats that were fed a vitamin D replete 
diet compared to rats on VDD diet(Baksi and Hughes 1982). In people with 
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depression, both dopamine and serotonin levels are depleted. Taken together, 
animal studies support the vitamin D hypothesis of depression. In this regard, 
several epidemiological studies also lend credence to this hypothesis (Hoogendijk et 
al. 2008; Jorde et al. 2006; Ganji et al. 2010).  
Ganji et al (2010) found that those with low Vitamin D blood serum levels were 
nearly twice as likely to develop depression that those who had higher levels. By far, 
the strongest evidence supporting a causal link between depression and VDD comes 
from randomised controlled trials (Jorde et al. 2008). In a double blind randomised 
controlled trial of 441 participants, Jorde et al (2008) compared the outcome of 
depression in three groups( two groups taking vitamin D of different strengths and 
one taking placebo). At one year, they found that those with low levels were 
significantly more depressed than those with adequate levels of vitamin D. Overall, 
the groups receiving vitamin D supplementation had improved depressive symptoms 
than those who received placebo. This finding among others has considerable 
implications for future public health and mental health nursing in particular.  
Implication for clinical practice  
Studies have demonstrated a clear link between VDD and mental health and its role 
as a therapeutic agent has attracted considerable interest. From a public health 
perspective, the use of vitamin D has the potential to alter health care in general and 
mental health nursing in particular. Vitamin D levels can be increased using 
inexpensive and well tolerated dietary supplements. In physical health, studies have 
demonstrated modest improvement in people who take vitamin D supplements 
towards health. Evidence suggest that taking vitamin D by older people has positive 
multiple outcomes including reduced falls, higher bone mineral density, and reduced 
fractures. There is potential therefore for a pivotal role in vitamin D supplementation 
as part of routine nursing care.  
In physical health disorders such as diabetes, the use of vitamin D supplements 
again shows promising results (von Hurst et al. 2010). In a randomised controlled 
trial that sought to improve the vitamin D status of women who were insulin resistant, 
Von Hurst et al(2010) found significant improvement in insulin sensitivity and a 
reduction in fasting insulin in the vitamin D supplementation group compared to 
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placebo. This finding is likely to find therapeutic application in mental health where a 
significant proportion of people also have type 2 diabetes.  
In depression, this vitamin has the potential to play a useful therapeutic role as 
demonstrated by a several studies that recorded an improvement in depressive 
symptoms after vitamin D supplementation. (Hogberg et al. 2012; Bertone-Johnson 
et al. 2011). A Norwegian trial of overweight subjects showed that those receiving a 
high dose of vitamin D (20,000 or 40,000 IU weekly) had a significant improvement 
in depressive symptoms after 1 year versus those receiving placebo (Jorde et al. 
2008). From a practical point of view, it is likely that in future, nurses will encourage 
patients to be exposed to light as part of a treatment plan. It is purported that a light 
exposure of between 20 to 30 minutes a day is sufficient for the skin to synthesise 
adequate vitamin. Moreover light therapy for non seasonal affective disorder shows 
promising results(Tuunainen et al. 2004). With regard to schizophrenia, there are 
currently several randomised controlled trials in process, testing the effect of vitamin 
D on numerous outcome measures including symptoms and cognition. Clearly, these 
prospects have the potential to modify nursing practice in future and this may include 
care for the pregnant.  
 During pregnancy, the foetus is entirely dependent on the mother for its supply of 
vitamin D. therefore maternal vitamin D supplementation during pregnancy is 
necessary and nurses have an important role to play in this regard. Relatively recent 
Cochrane review has provided evidence on the positive impact of vitamin D 
supplementation (De-Regil et al. 2012). Overall, it is likely that in future vitamin D 
may play a significant role in public mental health through primary preventative care 
of neurodevelopmental disorders like schizophrenia.  
Conclusion  
There is ample biological evidence suggesting the importance of vitamin D in the 
neurodevelopmental process, physical health and mental health in particular. Current 
mental health policy emphasises an intergrated approach of physical and mental 
health care and, this has wider implications for future mental health nursing. Based 
on the evidence presented in this paper, Vitamin D is likely to have an important role 
in routine nursing care. From a preventative vantage point, the peri-natal stage of 
development and care is critical. Good peri-natal care is known to have a positive 
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and lasting impact on good physical and mental health (Huang 2011). It is likely that 
nutritional care as a means to promoting good mental health care is likely to be 
integral in future nursing interventions. In this regard mental health nurses ought to 
familiarise themselves more with multifunctional role of this important hormone.  
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